| |
|
|
|
|
Ergo Science Corp.(ERGO)
|
|
|
|
|
|
|
|
|
| 123Jump Rating: |
|
Underwriters: |
SG Cowen
|
| |
|
|
Needham & Company, Inc.
|
| Status: |
|
|
|
| |
| Address: |
Charlestown Navy Yard, Fourth Floor
|
FiledDate: |
|
| |
100 First Avenue
|
|
|
| |
Charlestown,
|
Filed Price Range ($): |
|
| |
|
|
|
| Telephone: |
(617) 241- 6800 |
Filed Offer Amount ($ Million): |
$0.00 |
| |
|
|
|
| Fax: |
|
Shares Offered (Millions): |
2,500,000 |
| |
|
|
|
| Websites: |
|
Shares Outstanding (Millions): |
9,768,448 |
| |
|
|
|
| Management: |
Manuel Cincotta, Jr., Chairman
|
IPO Date: |
|
| |
Ronald H. Abrahams, Ph.D., Pres./CEO
|
|
|
| |
Alan T. Barber, CFO
|
Final Offer Price ($): |
$0.00 |
| |
|
|
|
| Industry: |
|
Final Offer Size (Millions of Shares): |
0.00 |
| |
|
|
|
| Employees: |
73 |
Final Offer Amount ($ Million): |
$0.00 |
| |
|
|
|
| Competitors: |
Bristol-Myers Squibb
|
S-1 Forms: |
|
| |
Bayer Pharmeceuticals
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
- Avoid 
- Value Gap 
- Short-Term Growth
- Long-Term Growth 
- Long-Term Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income Data |
| Year |
Revenues |
Costs |
Oper Income |
Taxes |
Net Income |
EPS |
| 1992
|
340.57 |
0.00 |
0.00 |
0.00 |
-3320.74 |
-.86 |
| 1993
|
107.71 |
5569 |
-5461 |
0.00 |
-5461.01 |
-1.52 |
| 1994
|
214.91 |
9175 |
-8960 |
0.00 |
-8959.84 |
-2.56 |
| 1995
|
94 |
22244 |
22150 |
0.00 |
-22149.95 |
-8.06 |
| 1996
|
1398 |
18580 |
17182 |
0.00 |
-17183 |
-1.57 |
|
|
|
|
|
|
|
| |
|
| |
|
|
